378 related articles for article (PubMed ID: 15254717)
1. Mitochondrial DNA mutations in chemical carcinogen-induced rat bladder and human bladder cancer.
Chen GF; Chan FL; Hong BF; Chan LW; Chan PS
Oncol Rep; 2004 Aug; 12(2):463-72. PubMed ID: 15254717
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial DNA mutations and 8-hydroxy-2'-deoxyguanosine Content in Japanese patients with urinary bladder and renal cancers.
Wada T; Tanji N; Ozawa A; Wang J; Shimamoto K; Sakayama K; Yokoyama M
Anticancer Res; 2006; 26(5A):3403-8. PubMed ID: 17094459
[TBL] [Abstract][Full Text] [Related]
3. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.
Shiina H; Igawa M; Urakami S; Shigeno K; Yoneda T; Terashima M; Deguchi M; Ribeiro-Filho L; Dahiya R
Cancer Res; 2001 Oct; 61(19):7101-9. PubMed ID: 11585741
[TBL] [Abstract][Full Text] [Related]
4. [Mitochondrial DNA mutations in lung cancer].
Jin XJ; Zhang JJ; Song Y; Gao YN; Cheng SJ
Ai Zheng; 2002 Jul; 21(7):715-8. PubMed ID: 12479093
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
Zhu W; Qin W; Bradley P; Wessel A; Puckett CL; Sauter ER
Carcinogenesis; 2005 Jan; 26(1):145-52. PubMed ID: 15375011
[TBL] [Abstract][Full Text] [Related]
6. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
[TBL] [Abstract][Full Text] [Related]
7. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma.
Lee HC; Li SH; Lin JC; Wu CC; Yeh DC; Wei YH
Mutat Res; 2004 Mar; 547(1-2):71-8. PubMed ID: 15013701
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer.
Wu CW; Yin PH; Hung WY; Li AF; Li SH; Chi CW; Wei YH; Lee HC
Genes Chromosomes Cancer; 2005 Sep; 44(1):19-28. PubMed ID: 15892105
[TBL] [Abstract][Full Text] [Related]
9. Detection of mitochondrial DNA mutations in nonmuscle invasive bladder cancer.
Guney AI; Ergec DS; Tavukcu HH; Koc G; Kirac D; Ulucan K; Javadova D; Turkeri L
Genet Test Mol Biomarkers; 2012 Jul; 16(7):672-8. PubMed ID: 22533676
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial genome instability and mtDNA depletion in human cancers.
Lee HC; Yin PH; Lin JC; Wu CC; Chen CY; Wu CW; Chi CW; Tam TN; Wei YH
Ann N Y Acad Sci; 2005 May; 1042():109-22. PubMed ID: 15965052
[TBL] [Abstract][Full Text] [Related]
11. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
[TBL] [Abstract][Full Text] [Related]
12. Novel heteroplasmic frameshift and missense somatic mitochondrial DNA mutations in oral cancer of betel quid chewers.
Tan DJ; Chang J; Chen WL; Agress LJ; Yeh KT; Wang B; Wong LJ
Genes Chromosomes Cancer; 2003 Jun; 37(2):186-94. PubMed ID: 12696067
[TBL] [Abstract][Full Text] [Related]
13. Heteroplasmic mutation of mitochondrial DNA D-loop and 4977-bp deletion in human cancer cells during mitochondrial DNA depletion.
Lee HC; Hsu LS; Yin PH; Lee LM; Chi CW
Mitochondrion; 2007; 7(1-2):157-63. PubMed ID: 17280876
[TBL] [Abstract][Full Text] [Related]
14. Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinoma.
Pejovic T; Ladner D; Intengan M; Zheng K; Fairchild T; Dillon D; Easley S; Dillon D; Marchetti D; Schwartz P; Lele S; Costa J; Odunsi K
Eur J Cancer; 2004 Nov; 40(16):2519-24. PubMed ID: 15519528
[TBL] [Abstract][Full Text] [Related]
15. Analysis of potential cancer biomarkers in mitochondrial DNA.
Jakupciak JP; Dakubo GD; Maragh S; Parr RL
Curr Opin Mol Ther; 2006 Dec; 8(6):500-6. PubMed ID: 17243485
[TBL] [Abstract][Full Text] [Related]
16. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas.
Liu VW; Shi HH; Cheung AN; Chiu PM; Leung TW; Nagley P; Wong LC; Ngan HY
Cancer Res; 2001 Aug; 61(16):5998-6001. PubMed ID: 11507041
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer.
Tan DJ; Bai RK; Wong LJ
Cancer Res; 2002 Feb; 62(4):972-6. PubMed ID: 11861366
[TBL] [Abstract][Full Text] [Related]
18. Somatic mitochondrial mutations in melanoma resection specimens.
Deichmann M; Kahle B; Benner A; Thome M; Helmke B; Näher H
Int J Oncol; 2004 Jan; 24(1):137-41. PubMed ID: 14654950
[TBL] [Abstract][Full Text] [Related]
19. MtDNA point mutations are associated with deletion mutations in aged rat.
Pak JW; Vang F; Johnson C; McKenzie D; Aiken JM
Exp Gerontol; 2005 Mar; 40(3):209-18. PubMed ID: 15763398
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
Máximo V; Lima J; Soares P; Botelho T; Gomes L; Sobrinho-Simões M
Mitochondrion; 2005 Oct; 5(5):333-40. PubMed ID: 16183030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
